SCHEMBL304217

SCHEMBL304217

CC(=O)C(C)CCCCCC(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.57
FFAR1 O14842 2/20 0.57
TSHR P16473 5/20 0.52
LMNA P02545 1/20 0.52
NFKB1 P19838 1/20 0.52
PMP22 Q01453 1/20 0.52
ALDH1A1 P00352 3/20 0.50
GSTK1 Q9Y2Q3 1/20 0.48
GPR84 Q9NQS5 7/20 0.48
PPARG P37231 6/20 0.48
PPARD Q03181 6/20 0.48
PPARA Q07869 6/20 0.48
HDAC11 Q96DB2 5/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
PTPN1 P18031 2/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
SLC22A8 Q8TCC7 1/20 0.48
MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14093813 1.00 FFAR4 (0.57) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL559468 1.00 FFAR4 (0.57) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL999059 0.98 FFAR4 (0.53) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL28041784 0.94 FFAR4 (0.52) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL10068076 0.91 CYP1A2 (0.50) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL2348647 0.91 CYP1A2 (0.50) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL12153332 0.86 CA1 (0.46) FFAR4FFAR1GPR84
SCHEMBL21998 0.84 CYP1A2 (0.67) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL3811423 0.84 CYP1A2 (0.67) FFAR4FFAR1TSHRLMNANFKB1
SCHEMBL11884635 0.84 PAOX (0.48) FFAR4FFAR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 250 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4685144-A1 NON-FLUORESCENT COMPOUND AND USES THEREOF SFC Co., Ltd. (KR) 2026-01-28 EP disclosed
US-20250084250-A1 AZAINDOLE CYANINE DYES, USES, AND METHODS OF PREPARATION LIFE TECHNOLOGIES CORP (US) 2025-03-13 US disclosed
WO-2024228496-A1 NON-FLUORESCENT COMPOUND AND USES THEREOF 에스에프씨 주식회사 2024-11-07 WO disclosed
US-20240182451-A1 AZAINDOLE CYANINE DYES, USES, AND METHODS OF PREPARATION Life Technologies Corporation 2024-06-06 US disclosed
EP-4373891-A2 AZAINDOLE CYANINE DYES, USES, AND METHODS OF PREPARATION Life Technologies Corporation (US) 2024-05-29 EP disclosed
CN-117529529-A Azaindole cyanine dye, application and preparation method 生命技术公司 2024-02-06 CN disclosed
US-20230270890-A1 FLUORESCENT COMPOUND FOR DETECTING BIOLOGICAL MATERIAL AND PREPARATION METHOD THEREOF BIOACTS CORPORATION (KR) 2023-08-31 US disclosed
WO-2023004356-A2 AZAINDOLE CYANINE DYES, USES, AND METHODS OF PREPARATION Life Technologies Corporation (US) 2023-01-26 WO disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
US-11041812-B2 Fluorogenic pH-sensitive dyes, film and kit comprising the same SFC CO., LTD. (KR) 2021-06-22 US disclosed
EP-1525265-A2 CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS CARNEGIE-MELLON UNIVERSITY (US) 2005-04-27 EP disclosed
US-6740755-B2 REACTING FIRST QUATERNISED INDOLENINE WITH AN IMINE COMPOUND IN A SOLVENT SELECTED FROM ACETIC ACID, ACETIC ANHYDRIDE AND MIXTURES THEREOF, FURTHER REACTING INTERMEDIATE HEMICYANINE WITH QUATERNIZED INDOLINE VISEN MEDICAL, INC. 2004-05-25 US disclosed
WO-2004039894-A2 CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS CARNEGIE MELLON UNIVERSITY (US) 2004-05-13 WO disclosed
EP-1322710-A1 MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES Molecular Probes Inc. (US) 2003-07-02 EP disclosed
US-20020077487-A1 Modified carbocyanine dyes and their conjugates MOLECULAR PROBES, INC. 2002-06-20 US disclosed
EP-1211294-A1 Improved process and method for the preparation of asymmetric monofunctionalised indocyanine labelling reagents and obtained compounds Innosense S.r.l. (IT) 2002-06-05 EP disclosed
US-20020064794-A1 Modified carbocyanine dyes and their conjugates MOLECULAR PROBES, INC. 2002-05-30 US disclosed
US-20020065421-A1 Process and method for the preparation of asymmetric monfunctionalised indocyanine labelling reagents and obtained compounds VISEN MEDICAL, INC. 2002-05-30 US disclosed
EP-1209205-A1 Improved process and method for the preparation of asymetric monofunctionalised indocyanine labelling reagents and obtained compounds Innosense S.r.l. (IT) 2002-05-29 EP disclosed
WO-2002026891-A1 MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES MOLECULAR PROBES, INC. (US) 2002-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020077487-A1 Modified carbocyanine dyes and their conjugates IK, CBR3, DRD5 FFAR4 3525/4885FFAR1 4405/4885TSHR 2666/4885
US-20230270890-A1 FLUORESCENT COMPOUND FOR DETECTING BIOLOGICAL MATERIAL AND PREPARATION METHOD THEREOF F12, MRGPRX4, C3AR1 FFAR4 3236/4885FFAR1 2934/4885TSHR 2823/4885
US-20240182451-A1 AZAINDOLE CYANINE DYES, USES, AND METHODS OF PREPARATION AZI2, IK, HCCS FFAR4 2882/4885FFAR1 3534/4885TSHR 2249/4885
US-20020065421-A1 Process and method for the preparation of asymmetric monfunctionalised indocyanine labelling reagents and obtained compounds IDO1, IDO2, AADAT FFAR4 2985/4885FFAR1 2075/4885TSHR 3821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.